R Squared’s Tyra Biosciences TYRA Stock Holding History

R Squared’s Portfolio TYRA Stock Details TYRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,480	Closed	-$20.6K	–	1442
2024 Q4	$20.6K	Buy	+1,480	New	+$26.9K	0.02%	859

Other funds holding TYRA

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Canaan Partners XI Menlo Park, California $127M AUM 217.49% 1-Year Est. Return

Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

R Squared's TYRA Position: Q1 2025 in Review

R Squared sold out of Tyra Biosciences (TYRA) in Q1 2025, closing a stake of 1,480 shares — an estimated $20.6K sold.

R Squared first reported a position in TYRA in Q4 2024 and held it in 1 quarter. The position peaked at $20.6K in Q4 2024. 117 funds tracked by Wall St. Rank hold TYRA as of Q1 2025.

R Squared reported no remaining Tyra Biosciences position as of Q1 2025 after selling out during the quarter.
R Squared sold 1,480 Tyra Biosciences shares in Q1 2025, an estimated $20.6K.
R Squared first reported a position in Tyra Biosciences in Q4 2024 and held it in 1 quarter.
R Squared's Tyra Biosciences position peaked at $20.6K in Q4 2024.
117 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2025.

Based on R Squared's 13F filing for Q1 2025, filed 9 May 2025.